Ciardullo, C. Et Al. 2016. The p53-MDM2 Antagonist RG7388 Activates p53 and Induces a Predominantly Pro-Apoptotic Gene Expression Signature in Chronic Lymphocytic Leukemia. 58th ASH Annual Meeting Exposition , (San Diego) , 893.

Ciardullo, C., Woodhouse, L., APTULLAHOĞLU, E., Wallis, J. P., Marr, H., Marshall, S., ... Bown, N.(2016). The p53-MDM2 Antagonist RG7388 Activates p53 and Induces a Predominantly Pro-Apoptotic Gene Expression Signature in Chronic Lymphocytic Leukemia . 58th ASH Annual Meeting Exposition (pp.893). San Diego

Ciardullo, Carmela Et Al. "The p53-MDM2 Antagonist RG7388 Activates p53 and Induces a Predominantly Pro-Apoptotic Gene Expression Signature in Chronic Lymphocytic Leukemia," 58th ASH Annual Meeting Exposition, San Diego, 2016

Ciardullo, Carmela Et Al. "The p53-MDM2 Antagonist RG7388 Activates p53 and Induces a Predominantly Pro-Apoptotic Gene Expression Signature in Chronic Lymphocytic Leukemia." 58th ASH Annual Meeting Exposition , San Diego, pp.893, 2016

Ciardullo, C. Et Al. (2016) . "The p53-MDM2 Antagonist RG7388 Activates p53 and Induces a Predominantly Pro-Apoptotic Gene Expression Signature in Chronic Lymphocytic Leukemia." 58th ASH Annual Meeting Exposition , San Diego, p.893.

@conferencepaper{conferencepaper, author={Carmela Ciardullo Et Al. }, title={The p53-MDM2 Antagonist RG7388 Activates p53 and Induces a Predominantly Pro-Apoptotic Gene Expression Signature in Chronic Lymphocytic Leukemia}, congress name={58th ASH Annual Meeting Exposition}, city={San Diego}, country={}, year={2016}, pages={893} }